These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36281525)

  • 21. Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau.
    Last AR; Burr SE; Weiss HA; Harding-Esch EM; Cassama E; Nabicassa M; Mabey DC; Holland MJ; Bailey RL
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2900. PubMed ID: 24967629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial.
    Arzika AM; Mindo-Panusis D; Abdou A; Kadri B; Nassirou B; Maliki R; Alsoudi AF; Zhang T; Cotter SY; Lebas E; O'Brien KS; Callahan EK; Bailey RL; West SK; Goodhew EB; Martin DL; Arnold BF; Porco TC; Lietman TM; Keenan JD;
    JAMA Netw Open; 2022 Aug; 5(8):e2228244. PubMed ID: 35997979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
    Harding-Esch EM; Edwards T; Sillah A; Sarr I; Roberts CH; Snell P; Aryee E; Molina S; Holland MJ; Mabey DC; Bailey RL
    PLoS Negl Trop Dis; 2009 Dec; 3(12):e573. PubMed ID: 20027217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program.
    Pant BP; Bhatta RC; Chaudhary JS; Awasthi S; Mishra S; Sharma S; Cuddapah PA; Gwyn SE; Stoller NE; Martin DL; Keenan JD; Lietman TM; Gaynor BD
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004462. PubMed ID: 26871898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
    Burr SE; Hart J; Samikwa L; Chaima D; Cooley G; Martin D; Masika M; Solomon AW; Bailey RL; Kalua K
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance Surveys for Reemergent Trachoma in Formerly Endemic Districts in Nepal From 2 to 10 Years After Mass Drug Administration Cessation.
    West SK; Zambrano AI; Sharma S; Mishra SK; Muñoz BE; Dize L; Crowley K; Gaydos CA; Rotondo LA
    JAMA Ophthalmol; 2017 Nov; 135(11):1141-1146. PubMed ID: 28973295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community-level Association between Clinical Trachoma and Ocular Chlamydia Infection after MASS Azithromycin Distribution in a Mesoendemic Region of Niger.
    Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Keenan JD; Lietman TM; Oldenburg CE
    Ophthalmic Epidemiol; 2019 Aug; 26(4):231-237. PubMed ID: 30957594
    [No Abstract]   [Full Text] [Related]  

  • 28. Follicular conjunctivitis caused by Chlamydia trachomatis in an infant Saharan population: molecular and clinical diagnosis.
    Javaloy J; Ferrer C; Vidal MT; Alió JL
    Br J Ophthalmol; 2003 Feb; 87(2):142-6. PubMed ID: 12543737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance for peri-elimination trachoma recrudescence: Exploratory studies in Ghana.
    Senyonjo L; Addy J; Martin DL; Agyemang D; Yeboah-Manu D; Gwyn S; Marfo B; Asante-Poku A; Aboe A; Mensah E; Solomon AW; Bailey RL
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009744. PubMed ID: 34543293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
    Yang JL; Hong KC; Schachter J; Moncada J; Lekew T; House JI; Zhou Z; Neuwelt MD; Rutar T; Halfpenny C; Shah N; Whitcher JP; Lietman TM
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):90-4. PubMed ID: 18689701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Ocular Chlamydia trachomatis Infection in Amhara Region, Ethiopia, after 8 Years of Trachoma Control Interventions.
    Nash SD; Chernet A; Weiss P; Nute AW; Zerihun M; Sata E; Gessese D; Jensen KA; Ayele Z; Melak B; Zeru T; Mengistu A; Abebe A; Seife F; Tadesse Z; Callahan EK
    Am J Trop Med Hyg; 2023 Feb; 108(2):261-267. PubMed ID: 36623484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of Chlamydia trachomatis eye infection in Tanzania by polymerase chain reaction/enzyme immunoassay.
    Bobo L; Munoz B; Viscidi R; Quinn T; Mkocha H; West S
    Lancet; 1991 Oct; 338(8771):847-50. PubMed ID: 1681215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for the progression of trachomatous scarring in a cohort of women in a trachoma low endemic district in Tanzania.
    Wolle MA; Muñoz BE; Naufal F; Kashaf MS; Mkocha H; West SK
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009914. PubMed ID: 34797827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trachomatous scarring among children in a formerly hyper-endemic district of Tanzania.
    Cox JT; Mkocha H; Munoz B; West SK
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006085. PubMed ID: 29232692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji.
    Macleod CK; Butcher R; Mudaliar U; Natutusau K; Pavluck AL; Willis R; Alexander N; Mabey DC; Cikamatana L; Kama M; Rafai E; Roberts CH; Solomon AW
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004798. PubMed ID: 27404379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serology, infection, and clinical trachoma as tools in prevalence surveys for re-emergence of trachoma in a formerly hyperendemic district.
    Odonkor M; Naufal F; Munoz B; Mkocha H; Kasubi M; Wolle M; West S
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009343. PubMed ID: 33861754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid assessment of trachoma among children living in rural northern India.
    Khanduja S; Jhanji V; Sharma N; Vashist P; Murthy GV; Gupta S; Satpathy G; Tandon R; Titiyal JS; Vajpayee RB
    Ophthalmic Epidemiol; 2009; 16(4):206-11. PubMed ID: 19874140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
    Ramadhani AM; Derrick T; Macleod D; Massae P; Malisa A; Mbuya K; Mtuy T; Makupa W; Roberts CH; Bailey RL; Mabey DCW; Holland MJ; Burton MJ
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007559. PubMed ID: 31306419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Isolation of Chlamydia trachomatis in trachomatous Moroccan patients].
    Takourt B; Milad A; Radouani F; Boura H; Guinet R; Benslimane A
    J Fr Ophtalmol; 1996; 19(8-9):527-32. PubMed ID: 8944135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for ocular chlamydia after three mass azithromycin distributions.
    Ayele B; Gebre T; Moncada J; House JI; Stoller NE; Zhou Z; Porco TC; Gaynor BD; Emerson PM; Schachter J; Keenan JD
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1441. PubMed ID: 22180804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.